[1] Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol, 2014, 61(3): 642-659.
[2] Faccioli J, Nardelli S, Gioia S, et al. Minimal hepatic encephalopathy affects daily life of cirrhotic patients: a viewpoint on clinical consequences and therapeutic opportunities. J Clin Med, 2022, 11(23):7246.
[3] Marjot T, Ray DW, Williams FR, et al. Sleep and liver disease: a bidirectional relationship. Lancet Gastroenterol Hepatol, 2021, 6(10): 850-863.
[4] Bajaj JS, Riggio O, Allampati S, et al. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study. Clin Gastroenterol Hepatol, 2013, 11(11): 1511-1516.
[5] Rose CF, Amodio P, Bajaj JS, et al. Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol, 2020, 73(6): 1526-1547.
[6] Shalimar, Rout G, Kumar R, et al. Persistent or incident hyperammonemia is associated with poor outcomes in acute decompensation and acute-on-chronic liver failure. JGH Open, 2020, 4(5): 843-850.
[7] Kumar R, Shalimar, Sharma H, et al. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol, 2012, 10(8): 925-931.
[8] Bosoi CR, Rose CF. Identifying the direct effects of ammonia on the brain. Metab Brain Dis, 2009, 24(1): 95-102.
[9] Martinez-Hernandez A, Bell KP, Norenberg MD. Glutamine synthetase: glial localization in brain. Science, 1977, 195(4284): 1356-1358.
[10] Rao KV, Panickar KS, Jayakumar AR, et al. Astrocytes protect neurons from ammonia toxicity. Neurochem Res, 2005, 30(10): 1311-1318.
[11] Niknahad H, Jamshidzadeh A, Heidari R, et al. Ammonia-induced mitochondrial dysfunction and energy metabolism disturbances in isolated brain and liver mitochondria, and the effect of taurine administration: relevance to hepatic encephalopathy treatment. Clin Exp Hepatol, 2017, 3(3): 141-151.
[12] Jo D, Kim BC, Cho KA, et al. The cerebral effect of ammonia in brain aging: blood-brain barrier breakdown, mitochondrial dysfunction, and neuroinflammation. J Clin Med, 2021, 10(13):2773.
[13] Sadasivam N, Kim YJ, Radhakrishnan K, et al. Oxidative stress, genomic integrity, and liver diseases. Molecules, 2022, 27(10):3159.
[14] Chen Z, Tian R, She Z, et al. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med, 2020, 152: 116-141.
[15] Lachmann V, Görg B, Bidmon H J, et al. Precipitants of hepatic encephalopathy induce rapid astrocyte swelling in an oxidative stress dependent manner. Arch Biochem Biophys, 2013, 536(2): 143-151.
[16] Farzaei MH, Zobeiri M, Parvizi F, et al. Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients, 2018, 10(7):855.
[17] Sureka B, Bansal K, Patidar Y, et al. Neurologic manifestations of chronic liver disease and liver cirrhosis. Curr Probl Diagn Radiol, 2015, 44(5): 449-461.
[18] Balachandran R C, Mukhopadhyay S, Mcbride D, et al. Brain manganese and the balance between essential roles and neurotoxicity. J Biol Chem, 2020, 295(19): 6312-6329.
[19] Liu K, Chen G, Ren S Y, et al. Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study. Neural Regen Res, 2019, 14(5): 850-857.
[20] Ferreira CR, Gahl WA. Disorders of metal metabolism. Transl Sci Rare Dis, 2017, 2(3-4): 101-139.
[21] Maeda H, Sato M, Yoshikawa A, et al. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology, 1997, 39(8): 546-550.
[22] Khalil M, Elbanhawy I, Elsherbiny A, et al. Neurological complications in recipients after living donor liver transplantation. Neurol India, 2020, 68(1): 146-151.
[23] Acar S, Dinckan A, Akyildiz M. Liver transplantation in hepatic myelopathy. Hepatol Forum, 2022, 3(2): 64-65.
[24] Aceto P, Perilli V, Lai C, et al. Postoperative cognitive dysfunction after liver transplantation. Gen Hosp Psychiatry, 2015, 37(2): 109-115.
[25] Bemeur C. Neurological complications post-liver transplantation: impact of nutritional status. Metab Brain Dis, 2013, 28(2): 293-300.
[26] Zivkovi? S A. Neurologic complications after liver transplantation. World J Hepatol, 2013, 5(8): 409-416.
[27] Rompianesi G, Montalti R, Cautero N, et al. Neurological complications after liver transplantation as a consequence of immunosuppression: univariate and multivariate analysis of risk factors. Transpl Int, 2015, 28(7): 864-869.
[28] Kornerup LS, Pflugrad H, Weissenborn K, et al. Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy? Hepat Med, 2019, 11: 41-46. |
